# Your Morning Coffee Is Now a Valid GLP-1 Companion - Date: 2026-04-02 - Category: Biotech & Life Sciences Lilly's orforglipron won FDA approval in 50 days under a controversial voucher deal, launching at $25/month for insured patients. Novo Nordisk says its oral Wegovy has better data. The real answer won't come from clinical trials. ---